JOGNN: Screening and the New Treatment for Postpartum Depression
Screening and the New Treatment for Postpartum Depression Abstract In August 2023, the U.S. Food and Drug Administration approved Zurzuvae (zuranolone) as the first oral medication to treat postpartum depression….
Read More from JOGNN: Screening and the New Treatment for Postpartum Depression